FFRct vs qXR-CTR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (FFRct) provides a detailed, non-invasive analysis of coronary artery blood flow from CCTA scans to diagnose coronary artery disease. Tool B (qXR-CTR) automates the measurement of the cardiothoracic ratio from chest X-rays to assess heart size and potential heart failure risk. While both are AI-powered cardiology and radiology tools, they address different clinical questions and utilize distinct imaging modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive diagnostic tool that uses AI to create personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease (CAD), helping to guide treatment strategies and revascularization decisions. In contrast, qXR-CTR is an AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, assisting in the assessment of heart size and potential heart failure risk.
FFRct Analysis specifically utilizes Coronary Computed Tomography Angiography (CCTA) scans as its input to generate detailed 3D models and blood flow analysis. Qure.ai's qXR-CTR, on the other hand, is designed to analyze standard chest X-ray images for its automated cardiothoracic ratio assessment.
FFRct provides personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing with FFRct values to determine the physiological significance of coronary lesions. qXR-CTR provides an automated measurement of the cardiothoracic ratio, which is a key indicator for assessing heart size and potential cardiomegaly, aiding in the diagnosis and monitoring of heart failure risk.